Is there a relationship between COVID-19 and sarcoidosis? A case report
<p>Mediastinal lymphadenopathy is rare in Coronavirus Disease-2019 (COVID-19) patients with mild clinical course. The frequency of lymphadenopathy increases in COVID-19 patients who develop Acute Respiratory Distress Syndrome (ARDS). In a 38-year-old male patient, mediastinal lymphadenopathy a...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Boek |
| Gepubliceerd in: |
Archives of Pulmonology and Respiratory Care - Peertechz Publications,
2022-11-19.
|
| Onderwerpen: | |
| Online toegang: | Connect to this object online. |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_aprc_000080 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Yasar Kucukardali |e author |
| 700 | 1 | 0 | |a Arzu Gunturk |e author |
| 700 | 1 | 0 | |a Mehmet Akif Ozturk |e author |
| 700 | 1 | 0 | |a Şenay Acikel |e author |
| 700 | 1 | 0 | |a Hatice Zeynep Ceylan |e author |
| 700 | 1 | 0 | |a Pınar Fırat |e author |
| 700 | 1 | 0 | |a Banu Salepci |e author |
| 245 | 0 | 0 | |a Is there a relationship between COVID-19 and sarcoidosis? A case report |
| 260 | |b Archives of Pulmonology and Respiratory Care - Peertechz Publications, |c 2022-11-19. | ||
| 520 | |a <p>Mediastinal lymphadenopathy is rare in Coronavirus Disease-2019 (COVID-19) patients with mild clinical course. The frequency of lymphadenopathy increases in COVID-19 patients who develop Acute Respiratory Distress Syndrome (ARDS). In a 38-year-old male patient, mediastinal lymphadenopathy and asymptomatic pulmonary embolism were detected during the third week of COVID-19 infection at home. Sarcoidosis was diagnosed with a finding of non-caseating granulomas. Even if it is asymptomatic, pulmonary embolism should be considered, especially in COVID-19 patients with high C - Reactive Protein (CRP) and D-dimer levels. If mediastinal lymphadenopathy is detected in mild COVID-19 cases, systemic diseases should be investigated. In severe COVID-19 cases, if lymphadenopathy continues despite a COVID-19 recovery, further investigation is required.</p> | ||
| 540 | |a Copyright © Yasar Kucukardali et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Case Report |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/aprc.000080 |z Connect to this object online. |